Merck completes acquisition of investigational B-cell depletion therapy, CN201 from Curon Biopharma: Rahway, New Jersey Thursday, October 3, 2024, 10:00 Hrs [IST] Merck, known as ...
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the completion of the acquisition of ...
MSD, a leading multinational pharmaceutical company successfully completes a first-of-its-kind strategic collaboration with ...
Sep. 18, 2024 — A team of scientists alarmed by the loss of biodiversity across the world due to climate change has proposed a new approach to managing vulnerable ... Rugged Falklands Landscape ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback